References
- Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133(6 Suppl): 546S-92S. https://doi.org/10.1378/chest.08-0678
- Fuster V, Ryden LE, Cannom DS, et al. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2011;57:e101-98.
- Lip GY, Agnelli G, Thach AA, Knight E, Rost D, Tangelder MJ. Oral anticoagulation in atrial fibrillation: a pan-European patient survey. Eur J Intern Med 2007;18:202-8. https://doi.org/10.1016/j.ejim.2006.11.005
- Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004;126(3 Suppl):204S-33S. https://doi.org/10.1378/chest.126.3_suppl.204S
- Lee KS, Choi SJ, Park SH, Kim HL, Min H, Park HY. Prevalence of atrial fibrillation in middle-aged people in Korea: the Korean Genome and Epidemiology Study. Korean Circ J 2008;38:601-5. https://doi.org/10.4070/kcj.2008.38.11.601
- Shen AY, Chen W, Yao JF, Brar SS, Wang X, Go AS. Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation. CNS Drugs 2008;22:815-25. https://doi.org/10.2165/00023210-200822100-00003
- Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly: the Framingham Study. Arch Intern Med 1987; 147:1561-4. https://doi.org/10.1001/archinte.1987.00370090041008
- Laupacis A, Boysen G, Connolly S, et al. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation: analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-57. https://doi.org/10.1001/archinte.1994.00420130036007
- Kim YH. Rhythm control versus rate control of atrial fibrillation: pharmacologic and non-pharmacologic therapy. Korean Circ J 2003;33: 553-8.
- van Walraven C, Hart RG, Singer DE, et al. Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 2002;288:2441-8. https://doi.org/10.1001/jama.288.19.2441
- Hylek EM, Go AS, Chang Y, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-26. https://doi.org/10.1056/NEJMoa022913
- Waldo AL, Becker RC, Tapson VF, Colgan KJ; NABOR Steering Committee. Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol 2005;46:1729-36. https://doi.org/10.1016/j.jacc.2005.06.077
- Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW. Ethnic disparities in stroke: epidemiology, acute care, and postacute outcomes. Stroke 2005;36:374-86. https://doi.org/10.1161/01.STR.0000153065.39325.fd
- van Walraven C, Jennings A, Oake N, Fergusson D, Forster AJ. Effect of study setting on anticoagulation control: a systematic review and metaregression. Chest 2006;129:1155-66. https://doi.org/10.1378/chest.129.5.1155
- Yasaka M, Minematsu K, Yamaquchi T. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation. Intern Med 2001;40:1183-8. https://doi.org/10.2169/internalmedicine.40.1183
- Miura T, Nishinaka T, Terada T, Yonezawa K. Relationship between aging and dosage of warfarin: the current status of warfarin anticoagulant therapy for Japanese outpatients in a department of cardiovascular medicine. J Cardiol 2009;53:355-60. https://doi.org/10.1016/j.jjcc.2008.12.003
- Atarashi H, Inoue H, Okumura K, Yamashita T, Kumagai N, Origasa H; JRHYTHM Registry Investigators. Present status of anticoagulation treatment in Japanese patients with atrial fibrillation: a report from the J-RHYTHM Resistry. Circ J 2011;75:1328-33. https://doi.org/10.1253/circj.CJ-10-1119
Cited by
- Effect of Left Atrial Activity After the Maze Procedure on Clinical and Echocardiographic Outcomes vol.78, pp.7, 2012, https://doi.org/10.1253/circj.cj-13-1390
- INR optimization based on stroke risk factors in patients with non-valvular atrial fibrillation vol.37, pp.6, 2012, https://doi.org/10.1007/s11096-015-0149-5
- Quality of anticoagulation management with warfarin among outpatients in a tertiary hospital in Addis Ababa, Ethiopia: a retrospective cross-sectional study vol.17, pp.None, 2012, https://doi.org/10.1186/s12913-017-2330-0
- The Absence of Atrial Contraction as a Predictor of Permanent Pacemaker Implantation after Maze Procedure with Cryoablation vol.50, pp.3, 2017, https://doi.org/10.5090/kjtcs.2017.50.3.163
- Status of international normalized ratio control and treatment patterns in patients with nonvalvular atrial fibrillation taking vitamin K antagonist with or without antiplatelet therapy: Results from vol.35, pp.4, 2012, https://doi.org/10.1002/joa3.12183